Free Trial
ASX:MDC

Medlab Clinical (MDC) Stock Price, News & Analysis

Medlab Clinical logo

About Medlab Clinical Stock (ASX:MDC)

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
36,677 shs
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Medlab Clinical Limited, a biotechnology company, researches, develops, and pre-commercializes pharmaceutical and nutraceutical products in Australia. Its drug candidate includes NanaBis, a buccal spray from cannabis oil extract for oncology and pain management; and NanoCBD, a buccal spray from hemp oil extract for mental health. The company also develops NanoCelle, a patented sub-micron drug delivery platform that allows passive diffusion of active pharmaceutical ingredients directly into the bloodstream through oral-buccal, sublingual, intranasal, and transdermal or topical delivery. In addition, it offers virtual clinic services. The company was founded in 2012 and is headquartered in Botany, Australia.

Receive MDC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Medlab Clinical and its competitors with MarketBeat's FREE daily newsletter.

MDC Stock News Headlines

Medlab Clinical Faces Steep Revenue Decline and Loss
Child Care on College Campuses: What to Know
5 Stocks that could triple in a week
Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942%, and 12,592% in 2020. Now their next one could be here.
Clinical Laboratory Technician Salary
See More Headlines

MDC Stock Analysis - Frequently Asked Questions

Based on aggregate information from My MarketBeat watchlists, some other companies that Medlab Clinical investors own include Magellan Financial Group (MFG), iSignthis (ISX), FBR (FBR), Embark Early Education (EVO), Dacian Gold (DCN), Constellation Technologies (CT1) and Bod Australia (BDA).

Industry, Sector and Symbol

Sector
Medical
Industry
Biotechnology
Sub-Industry
Construction
CIK
N/A
Fax
N/A
Employees
1,640
Year Founded
N/A

Profitability

Net Income
$-3,940,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$-1,470,000.00
Book Value
A($0.31) per share

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
0.89
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for November 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report

This page (ASX:MDC) was last updated on 11/18/2024 by MarketBeat.com Staff
From Our Partners